AR058574A1 - Asociacion de un inhibidor de la corriente sinusal i y de un inhibidor de la enzima de conversion y composiciones farmaceuticas que la contienen - Google Patents

Asociacion de un inhibidor de la corriente sinusal i y de un inhibidor de la enzima de conversion y composiciones farmaceuticas que la contienen

Info

Publication number
AR058574A1
AR058574A1 ARP060105639A ARP060105639A AR058574A1 AR 058574 A1 AR058574 A1 AR 058574A1 AR P060105639 A ARP060105639 A AR P060105639A AR P060105639 A ARP060105639 A AR P060105639A AR 058574 A1 AR058574 A1 AR 058574A1
Authority
AR
Argentina
Prior art keywords
inhibitor
association
current
sinusal
pharmaceutical compositions
Prior art date
Application number
ARP060105639A
Other languages
English (en)
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36685870&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR058574(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR058574A1 publication Critical patent/AR058574A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)

Abstract

Asociacion que contiene un inhibidor selectivo y específico e la corriente sinusal I (ivabradina, entre otros), y un agente inhibidor de la enzima de conversion de la angiotensina. (perindopril, entre otros).
ARP060105639A 2005-12-21 2006-12-20 Asociacion de un inhibidor de la corriente sinusal i y de un inhibidor de la enzima de conversion y composiciones farmaceuticas que la contienen AR058574A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513006A FR2894825B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
AR058574A1 true AR058574A1 (es) 2008-02-13

Family

ID=36685870

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105639A AR058574A1 (es) 2005-12-21 2006-12-20 Asociacion de un inhibidor de la corriente sinusal i y de un inhibidor de la enzima de conversion y composiciones farmaceuticas que la contienen

Country Status (42)

Country Link
US (2) US20070142355A1 (es)
EP (2) EP1800678B1 (es)
JP (2) JP4705564B2 (es)
KR (2) KR100907583B1 (es)
CN (1) CN101015557B (es)
AP (1) AP2119A (es)
AR (1) AR058574A1 (es)
AT (1) ATE508742T1 (es)
AU (1) AU2006252210B2 (es)
BR (1) BRPI0605517A (es)
CA (1) CA2571644C (es)
CO (1) CO5790168A1 (es)
CR (1) CR8820A (es)
CY (1) CY1111575T1 (es)
DK (1) DK1800678T3 (es)
EA (1) EA011253B1 (es)
ES (1) ES2366570T3 (es)
FR (1) FR2894825B1 (es)
GE (1) GEP20094604B (es)
GT (1) GT200600522A (es)
HK (1) HK1106444A1 (es)
HR (1) HRP20110532T1 (es)
IL (1) IL180204A (es)
JO (1) JO2699B1 (es)
MA (1) MA28723B1 (es)
ME (1) ME01958B (es)
MX (1) MXPA06014885A (es)
MY (1) MY146956A (es)
NO (1) NO337640B1 (es)
NZ (1) NZ552221A (es)
PE (2) PE20071004A1 (es)
PL (1) PL1800678T3 (es)
PT (1) PT1800678E (es)
RS (1) RS51731B (es)
SA (1) SA06270480B1 (es)
SG (2) SG133545A1 (es)
SI (1) SI1800678T1 (es)
TW (1) TWI369206B (es)
UA (1) UA86417C2 (es)
UY (1) UY30023A1 (es)
WO (1) WO2007077327A1 (es)
ZA (1) ZA200610824B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
FR2961105B1 (fr) 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013116738A1 (en) * 2012-02-03 2013-08-08 Cardeus Pharmaceuticals, Inc. Drug formulations
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
EP1402066A4 (en) * 2001-06-08 2008-10-22 Ortho Mcneil Pharm Inc PAIN TREATMENT WITH HYPERPOLARIZATION ACTIVATED CHANNELS CONTROLLED BY CYCLIC NUCLEOTIDE AS ATTACK POINT
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
US20040242565A1 (en) * 2001-09-11 2004-12-02 Yoshinori Toshima Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
DE60200160T2 (de) * 2002-07-25 2004-11-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
ME01958B (me) 2011-10-31
CN101015557A (zh) 2007-08-15
CR8820A (es) 2007-08-28
IL180204A (en) 2014-02-27
CY1111575T1 (el) 2015-10-07
AP2006003859A0 (en) 2006-12-31
MXPA06014885A (es) 2009-02-11
JP4705564B2 (ja) 2011-06-22
ES2366570T3 (es) 2011-10-21
ATE508742T1 (de) 2011-05-15
RS51731B (en) 2011-10-31
SI1800678T1 (sl) 2011-08-31
DK1800678T3 (da) 2011-08-15
SG173243A1 (en) 2011-08-29
WO2007077327A1 (fr) 2007-07-12
PL1800678T3 (pl) 2011-08-31
NO337640B1 (no) 2016-05-23
UA86417C2 (ru) 2009-04-27
PE20071004A1 (es) 2007-11-17
ZA200610824B (en) 2008-06-25
CN101015557B (zh) 2010-12-08
EA011253B1 (ru) 2009-02-27
JO2699B1 (en) 2013-03-03
HRP20110532T1 (hr) 2011-08-31
MA28723B1 (fr) 2007-07-02
MY146956A (en) 2012-10-15
US20070142355A1 (en) 2007-06-21
AU2006252210B2 (en) 2012-04-26
AU2006252210A1 (en) 2007-07-05
US20120196850A1 (en) 2012-08-02
AP2119A (en) 2010-04-21
TWI369206B (en) 2012-08-01
EP2298297A1 (fr) 2011-03-23
GT200600522A (es) 2007-07-25
JP2007169283A (ja) 2007-07-05
GEP20094604B (en) 2009-02-10
TW200744608A (en) 2007-12-16
KR20090047424A (ko) 2009-05-12
IL180204A0 (en) 2008-01-20
KR20070066921A (ko) 2007-06-27
BRPI0605517A (pt) 2007-10-16
CA2571644A1 (fr) 2007-06-21
NO20065905L (no) 2007-06-22
SG133545A1 (en) 2007-07-30
UY30023A1 (es) 2007-01-31
KR100907583B1 (ko) 2009-07-14
EA200602155A1 (ru) 2007-08-31
HK1106444A1 (en) 2008-03-14
EP1800678A1 (fr) 2007-06-27
PE20110116A1 (es) 2011-03-02
FR2894825A1 (fr) 2007-06-22
CA2571644C (fr) 2011-03-08
FR2894825B1 (fr) 2010-12-03
CO5790168A1 (es) 2007-08-31
JP2011079854A (ja) 2011-04-21
PT1800678E (pt) 2011-07-12
NZ552221A (en) 2008-05-30
EP1800678B1 (fr) 2011-05-11
SA06270480B1 (ar) 2011-02-23

Similar Documents

Publication Publication Date Title
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
AR058574A1 (es) Asociacion de un inhibidor de la corriente sinusal i y de un inhibidor de la enzima de conversion y composiciones farmaceuticas que la contienen
EA200701918A1 (ru) Белок липокалин
AR043150A1 (es) Composicion oral que contiene enzimas con estabilidad mejorada
NO20080991L (no) Bazedoksifen acetat formuleringer
JO2675B1 (en) A new association between the IF inhibitor in the sinus node and the calcium inhibitor and its pharmaceutical compounds
PA8795401A1 (es) Asociacion entre un antiaterotrombotico y un inhibidor de la enzima de conversion de la angiotensina
UY30022A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor de la enzima de conversion y las composiciones farmaceuticas que la contienen
CU23733A3 (es) Composición que comprende un inhibidor selectivo de la corriente sinusal if y de un inhibidor cálcico
CU23732A3 (es) Nueva asociación de un inhibidor de la corriente sinusal if y de un inhibidor de la enzima de conversión
TNSN08335A1 (fr) Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
UY29776A1 (es) Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen
TNSN06424A1 (fr) Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
UY34598A (es) Antranilamidas insecticidas
MX2007002849A (es) Composiciones con enzimas estables al vapor.
TW200505868A (en) New synerglstic combinations

Legal Events

Date Code Title Description
FC Refusal